Today KARL STORZ Endoscopy-America, Inc., announced the commercial launch of...

5/17/18: "In an era of antibiotic-resistant bacteria, we share a responsibility with our customers to maintain the safety of endoscopes," said Kurt Heine, Group Vice President, Endoscopy Division at Olympus America Inc. "From endoscopic procedures to transport, reprocessing and storage, endoscopes are at risk of jostling-related damage or retained moisture that can invite bacteria. A strategy to provide more than disinfection but also drying and transport protection will aid in the fight against bacteria. Our video guide coupled with our new transport and storage products will help technicians fight against bacteria and protect their valuable equipment during an endoscope's complete journey throughout the day."

5/17/18: Brainomix started as a spin-off from the University of Oxford in 2010 and has evolved into a world-leading, AI-based medical imaging software company dedicated to improving outcomes of patients with neurological and cerebrovascular disorders.

5/17/18: The prospective trial demonstrated that using MiCheck® could reduce the number of patients (with a clinically elevated PSA) proceeding to biopsy by up to 58%.

5/17/18: This is exemplified in the case of two-year-old Dexter Clark, who recently received a larger-than-average kidney from his father, Brendan Clark. 3D printing played an important role in the operation, according to Mr. Pankaj Chandak, Transplant Registrar at Guy’s and St Thomas’ NHS Foundation Trust.

5/16/18: "Patients with bifurcation lesions present a unique challenge for interventional cardiologists. This study will help us evaluate these patients in a controlled setting, which will help expand our knowledge base," said Matthew J. Price, M.D., interventional cardiologist at Scripps Clinic in La Jolla, Calif., and national principal investigator of the Bifurcation Cohort of the RESOLUTE ONYX Post-Approval Study. "The unique design of Resolute Onyx DES may be well-suited to treat bifurcation lesions in a wide range of vessel sizes."

5/16/18: “At Nicklaus Children’s we value the importance of investing in technology that enhances comfort and safety for our patients. The OmniTom is a step towards that continued commitment, by reducing the amount of radiation children are exposed to while enhancing safety for some of the most critical patients in our care,” said Sheryl Selinsky, Director of Radiology at Nicklaus Children’s Hospital.

5/16/18: 1 Year Results from the study of UroLift System for the obstructive median lobe twill be presented as a late-breaking abstract.

5/16/18: "We are pleased to have enrolled the first patients and to have a leadership role in the TIGER study. Stentrievers are now the gold standard for treating ischemic stroke, and TIGERTRIEVER is a new generation stentriever. Its unique design will hopefully show that it addresses the limitations of current devices and will improve patient outcomes," stated Dr. Rishi Gupta.

5/16/18: The results show MINIject to be safe and highly effective in achieving significant intraocular pressure (IOP) reduction in glaucoma patients.

5/15/18: “In my opinion, using RAPID ASPECTS increases the likelihood of getting a reliable ASPECT score, independent of the individual skills and experience of the clinician. This tool is therefore particularly suitable for primary stroke centers with a smaller number of cases,” said Dr. Benjamin Friedrich, docent and physician in the Department of Diagnostic and Interventional Neuroradiology at the Klinikum rechts der Isar in Munich. “Early and reliable information makes it possible to quickly understand the prognosis of a patient.”

5/15/18: Integrated classifier (Xpresys Lung 2®) provides simple and accurate method of distinguishing benign from malignant lung nodules.

5/14/18: The study will involve four National Health System Hospitals, led by Professor José Luis Calleja, MD from Hospital Universitario Puerta de Hierro Majadahonda - Universidad Autónoma de Madrid, as Principal Investigator.

5/14/18: CurveBeam President & CEO Arun Singh said, "CurveBeam continues to elevate the standard of care for orthopedic extremity imaging, and introduction of the LineUP device is another solid step upwards."

5/14/18: "INSIGHTEC is committed to supporting research that extends the applications and potential of focused ultrasound, to improve the lives of people living with Parkinson's disease with a much less invasive approach than conventional surgery," commented Maurice R. Ferré MD, INSIGHTEC'S CEO and Chairman of the Board of Directors.